← Back to Search
Intracellular Localization Of Hyaluronan In Proliferating Cells
S. Evanko, T. Wight
Published 1999 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Hyaluronan is a high molecular weight glycosaminoglycan found in the extracellular matrix of many tissues, where it is believed to promote cell migration and proliferation. It was recently shown that hyaluronan-dependent pericellular matrix formation is a rapid process that occurs as cells detach during mitosis. Growing evidence for intracellular hyaluronan in tissues in vivo, together with evidence of intracellular hyaluronan binding molecules, prompted us to examine hyaluronan distribution and uptake as well as hyaluronan binding sites in cells and their relationship to cell proliferation in vitro, using a biotinylated hyaluronan binding protein and fluorescein-labeled hyaluronan. In permeabilized smooth muscle cells and fibroblasts, hyaluronan staining was seen in the cytoplasm in a diffuse, network-like pattern and in vesicles. Nuclear hyaluronan staining was observed and confirmed by confocal microscopy and was often associated with nucleoli and nuclear clefts. After serum stimulation of 3T3 cells, there was a dramatic increase in cytoplasmic hyaluronan staining, especially during late prophase/early prometaphase of mitosis. In contrast, unstimulated cells were negative. There was a pronounced alteration in the amount and distribution of hyaluronan binding sites, from a mostly nucleolar distribution in unstimulated cells to one throughout the cytoplasm and nucleus after stimulation. Exogenous fluorescein-labeled hyaluronan was taken up avidly into vesicles in growing cells but was localized distinctly compared to endogenous hyaluronan, suggesting that hyaluronan in cells may be derived from an intracellular source. These data indicate that intracellular hyaluronan may be involved in nucleolar function, chromosomal rearrangement, or other events in proliferating cells.
This paper references
Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action
L. Collis (1998)
aluronan - phospholipid interactions
I Pasqualli-Ronchetti (1997)
Cell cycle‐dependent nuclear location of the matricellular protein SPARC: Association with the nuclear matrix
M. D. Gooden (1999)
I. Pasquali-Ronchetti (1997)
Preparation and properties of fluorescein-labelled hyaluronate.
A. de Belder (1975)
High‐resolution localization of hyaluronic acid in the golden hamster oocyte‐cumulus complex by use of a hyaluronidase‐gold complex
F. K. Kan (1990)
Developmental role of hyaluronate.
B. Toole (1982)
Association of hyaluronan with rat vascular endothelial and smooth muscle cells.
P. Eggli (1995)
Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum
J. A. Ripellino (1988)
Correlations between heparan sulfate metabolism and hepatoma growth
M. Ishihara (1989)
Immunoelectron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain
J. A. Ripellino (1989)
Localization of sulfated glycosaminoglycans within cell nuclei by high-resolution autoradiography.
H. Fromme (1976)
High-resolution cytochemistry of neuraminic and hexuronic acid-containing macromolecules applying the enzyme-gold approach.
I. Londono (1988)
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase*
S. Zhang (1998)
Inter-α-inhibitor Is Required for the Formation of the Hyaluronan-containing Coat on Fibroblasts and Mesothelial Cells (*)
A. Blom (1995)
Correlations between hyaluronan and epidermal proliferation as studied by [3H]glucosamine and [3H]thymidine incorporations and staining of hyaluronan on mitotic keratinocytes.
R. Tammi (1991)
Molecular Cloning of Human Fibroblast Hyaluronic Acid-binding Protein Confirms Its Identity with P-32, a Protein Co-purified with Splicing Factor SF2
T. B. Deb (1996)
Nuclear Targeting of Secretory Proteins
J. Henderson (1997)
Increased hyaluronate synthesis is required for fibroblast detachment and mitosis.
M. Brecht (1986)
Interrelationships of nuclear architecture with gene expression: Functional encounters on a long and winding road
G. Stein (1998)
CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis.
W. Knudson (1996)
Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction.
V. Hascall (1974)
Are glycoproteins and glycosaminoglycans components of the eukaryotic genome?
G. Stein (1975)
Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells.
E. Papakonstantinou (1995)
A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells
N. Fedarko (1986)
Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan
N. Fedarko (1989)
A Novel Glycosaminoglycan-binding Protein Is the Vertebrate Homologue of the Cell Cycle Control Protein, Cdc37 (*)
N. Grammatikakis (1995)
Pattern of glycosaminoglycans and glycoproteins associated with nuclei of regenerating liver of rat.
K. Furukawa (1979)
Glycosaminoglycans and glycoproteins associated with rat brain nuclei.
R. K. Margolis (1976)
CD44 positive macrophages take up hyaluronan during lung development.
C. Underhill (1993)
The dynamic structure of the pericellular matrix on living cells
G. M. Lee (1993)
Growth-related production of proteoglycans and hyaluronic acid in synchronous arterial smooth muscle cells.
E. Deudon (1992)
Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts.
P. Heldin (1989)
Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription
S. J. Busch (1992)
Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein.
M. Hofmann (1998)
Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
S. Evanko (1999)
Changes in distribution of nuclear matrix antigens during the mitotic cell cycle
N. Chaly (1984)
Isolation and identification of glycosaminoglycans associated with purified nuclei from rat liver.
K. Furukawa (1977)
This paper is referenced by
Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase.
N. Comtesse (2001)
Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production.
P. Heldin (2019)
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
Hyaluronan-dependent pericellular matrix.
S. Evanko (2007)
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
Detection of cell type and marker specificity of nuclear binding sites for anionic carbohydrate ligands
M. Chovanec (2004)
The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy.
U. Bertheim (2004)
Intracellular hyaluronan: a new frontier for inflammation?
Vincent C. Hascall (2004)
Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.
S. Al-Qadi (2013)
Hyaluronan: is bigger better?
T. Camenisch (2000)
Detection of a specific pattern of hyaluronan oligosaccharides and their binding proteins in human ovarian tumour
S. P. Kolapalli (2016)
In vitro investigation of hyaluronan-based polymeric micelles for drug delivery into the skin: the internalization pathway.
Jana Starigazdová (2019)
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
Einfluss von 4-Methylumbelliferon, einem Hyaluronsäure-Syntheseinhibitor, auf atherosklerotisch bedingte Gefäßveränderungen ApoE-defizienter Mäuse
N. Nagy (2010)
Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes.
M. Igarashi (2011)
Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury.
J. George (2004)
Distribution spaces for hyaluronan and albumin in rat tail tendons.
K. Aukland (2001)
A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases.
P. S. Apaolaza (2014)
Chitosan-based nanoparticles studied by isothermal titration calorimetry
Iolanda Fotticchia (2016)
Chapter 17 – Hyaluronan in Aging
M. O. Longas (2004)
Hyaluronan Synthases and RHAMM as Synergistic Mediators of Malignancy in B Lineage Cancers
L. Pilarski (2004)
Hyaluronan-Cell Interactions in Cancer and Vascular Disease*
B. Toole (2002)
Versican localizes to the nucleus in proliferating mesenchymal cells.
J. Carthy (2015)
Hyaluronan-CD44-ERK1/2 Regulate Human Aortic Smooth Muscle Cell Motility during Aging*
D. Vigetti (2008)
Hereditary cutaneous mucinosis in shar pei dogs is associated with increased hyaluronan synthase-2 mRNA transcription by cultured dermal fibroblasts.
G. Zanna (2009)
Expression of Hyaluronan in human tumor progression
Rajeev K. Boregowda (2006)
Hyaluronan Regulates Bone Morphogenetic Protein-7-dependent Prevention and Reversal of Myofibroblast Phenotype*
Adam C Midgley (2015)
Moderne konservative Arthrosetherapiekonzepte in der Praxis
J. Jerosch (2007)
G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes.
J. J. Embry (2003)
Intracellular Hyaluronan in Arterial Smooth Muscle Cells: Association with Microtubules, RHAMM, and the Mitotic Spindle
S. Evanko (2004)
Hyaluronan matrices in pathobiological processes
A. Wang (2011)
HYALURONIDAS EREDUCE SHUMA NBREAS TCANCE RXENOGRAFT SIN
Sci Dmice (2002)See more